Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sandra Huicochea Castellanos"'
Autor:
Kritika Subramanian, Juana Martinez, Sandra Huicochea Castellanos, Jana Ivanidze, Himanshu Nagar, Sean Nicholson, Trisha Youn, Jones T. Nauseef, Scott Tagawa, Joseph R. Osborne
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Prostate cancer (PC) staging with conventional imaging often includes multiparametric magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest, abdomen, and pelvis, and whole-body bone scintigraphy. The recent developme
Externí odkaz:
https://doaj.org/article/bc6251fb20554b56bfa0eda52d6df57a
Autor:
Juana Martinez, Kritika Subramanian, Sandra Huicochea Castellanos, Charlene Thomas, Arindam Roy Choudhury, Brett Muench, Scott T. Tagawa, Naga Vara Kishore Pillarsetty, Joseph R. Osborne
Publikováno v:
Translational Oncology, Vol 28, Iss , Pp 101593- (2023)
The clinical utility of gallium 68 (68Ga)-PSMA PET for the diagnosis and management of prostate cancer is driven in part by radioisotope availability and production costs. This study evaluates the equivalence between the two manufacturing processes f
Externí odkaz:
https://doaj.org/article/acebfe7accda4263bb0a39aa5277437b
Autor:
Juana Martinez, Kritika Subramanian, Daniel Margolis, Elisabeth O'Dwyer, Joseph Osborne, Yuliya Jhanwar, Himanshu Nagar, Nicholas Williams, Arindam RoyChoudhury, Gabriela Madera, John Babich, Sandra Huicochea Castellanos
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101242- (2022)
Background: The primary objective was to compare the overall diagnostic performance, presented as detection rate of 68Ga-PSMA-HBED-CC positron emission tomography/magnetic resonance imaging (PSMA PET/MRI) versus conventional, multiparametric MRI (mpM
Externí odkaz:
https://doaj.org/article/d82a1ce971a34dff967ae2e5b48f87b2
Autor:
Giuseppe Corrias, Marco Erta, Marcello Sini, Claudia Sardu, Luca Saba, Usman Mahmood, Sandra Huicochea Castellanos, David Bates, Nicola Mondanelli, Brian Thomsen, Gabriella Carollo, Peter Sawan, Lorenzo Mannelli
Publikováno v:
Dose-Response, Vol 19 (2021)
Introduction: Oncologic patients who develop chemotherapy-associated liver injury (CALI) secondary to chemotherapy treatment tend to have worse outcomes. Biopsy remains the gold standard for the diagnosis of hepatic steatosis. The purpose of this art
Externí odkaz:
https://doaj.org/article/0a3f372007bc4d05bac63d9147e4cca8
Autor:
Kritika Subramanian, Juana Martinez, Sandra Huicochea Castellanos, Jana Ivanidze, Himanshu Nagar, Sean Nicholson, Trisha Youn, Jones T. Nauseef, Scott Tagawa, Joseph R. Osborne
Prostate cancer (PC) staging with conventional imaging often includes multiparametric magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest, abdomen, and pelvis, and whole-body bone scintigraphy. The recent development of hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2a755c18761a7776c2af2d656d8473a
https://lirias.kuleuven.be/handle/20.500.12942/722215
https://lirias.kuleuven.be/handle/20.500.12942/722215
Autor:
Jessica Flynn, Darragh Halpenny, Jeffrey Girshman, Andrew J. Plodkowski, Michelle S. Ginsberg, Marinela Capanu, Andrew Pagano, Matthew D. Hellmann, Junting Zheng, Sandra Huicochea Castellanos, Hira Rizvi
Publikováno v:
Lung Cancer
Objectives To investigate the inter- and intra-reader agreement of immune Response Evaluation Criteria in Solid Tumors (iRECIST) and Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) in patients with lung cancer treated with immun
Autor:
Jones T. Nauseef, Michael Philip Sun, Charlene Thomas, Mahelia Bissassar, Amie Patel, Angela Tan, Escarleth Fernandez, Zachary Davidson, Tessa Chamberlain, Kara Earle, Rebecca Wunder, Sandra Huicochea Castellanos, Peter Gregos, Joseph Osborne, Karla V. Ballman, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Neil Harrison Bander, Scott T. Tagawa
Publikováno v:
Journal of Clinical Oncology. 41:TPS288-TPS288
TPS288 Background: As prostate-specific membrane antigen targeted radiotherapy (PSMA-TRT) is now an active standard-of-care treatment in mCRPC, ongoing studies with alternative approaches to targeting PSMA will increasingly need to consider the conse
Autor:
Michael Philip Sun, Jones T. Nauseef, Jessica Palmer, Joseph Earl Thomas, Judith Stangl-Kremser, Mahelia Bissassar, Sandra Huicochea Castellanos, Joseph Osborne, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Neil Harrison Bander, Scott T. Tagawa
Publikováno v:
Journal of Clinical Oncology. 41:181-181
181 Background: Only a small fraction of patients with PC respond to immunotherapy; radiation increases responses. PSMA targeted radionuclide therapy (PSMA-TRT) radiates multiple sites of disease simultaneously. ARSI can lead to radiosensitization an
Autor:
John W. Babich, Yuliya Jhanwar, Himanshu Nagar, Daniel Margolis, Nicholas Williams, Sandra Huicochea Castellanos, Joseph R. Osborne, Gabriela Madera, Arindam RoyChoudhury, Juana Martinez, Elisabeth O'Dwyer, Kritika Subramanian
Publikováno v:
Translational Oncology
Translational Oncology, Vol 15, Iss 1, Pp 101242-(2022)
Translational Oncology, Vol 15, Iss 1, Pp 101242-(2022)
Highlights • PSMA PET/MRI has a higher true positive rate and sensitivity than mpMRI in patients with biochemically recurrent prostate cancer. • The true positive rate for PSMA PET/MRI was significantly greater in patients who were post prostatec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4c249e556afdf218ba62e0dc955c2d
https://lirias.kuleuven.be/handle/20.500.12942/701708
https://lirias.kuleuven.be/handle/20.500.12942/701708
Autor:
Peter J. Allen, Serena Monti, Andrea Agostini, Jean Carter, David Aramburu-Nunez, Mark E. Robson, Deborah J. Goldfrank, Olga Smelianskaia, Ramesh Paudyal, Lorenzo Di Cesare Mannelli, Sandra Huicochea-Castellanos, Marinela Capanu, Junting Zheng, Mitchell C. Raeside, Amita Shukla-Dave, Bettina Conti, Debra A. Mangino, David P. Kelsen, Giuseppe Corrias, Maggie Fung, Richard K. G. Do
Publikováno v:
Eur Radiol
To develop and optimize a rapid magnetic resonance imaging (MRI) screening protocol for pancreatic cancer to be performed in conjunction with breast MRI screening in breast cancer susceptibility gene (BRCA)–positive individuals. An IRB-approved pro